GSK429286A
-
Catalog number2637-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name4-[4-(Trifluoromethyl)phenyl]-N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide; GSK429286
-
DescriptionGSK429286A is a potent and selective Rho-Kinase (ROCK) inhibitor (IC₅₀ = 14 and 63 nM for ROCK1 and ROCK2, respectively). ROCK inhibitors have been found to prevent apoptosis, as well as enhance the survival and cloning efficiency of dissociated human embryonic stem (ES) cells without affecting their self-renewal properties or pluripotency.
-
CAS Number864082-47-3
-
Structure AvailableY
-
Salt FormNo
-
Molecular FormulaC₂₁H₁₆F₄N₄O₂
-
Molecular Weight432.27
-
Cell PermeableYes
-
Purity>98% by HPLC
-
SolubilitiesDMSO (~40 mg/ml) or EtOH (~10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective Rho-kinase (ROCK) inhibitor
-
Storage Condition-20 ̊C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
MDL NumberMFCD16618404
-
PubChem CID11373846
-
SMILESCC1=C(C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(C=C4C(=C3)C=NN4)F
-
InChinChI=1S/C21H16F4N4O2/c1-10-19(20(31)28-17-6-12-9-26-29-16(12)8-15(17)22)14(7-18(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-6,8-9,14H,7H2,1H3,(H,26,29)(H,27,30)(H,28,31)
-
InChi KeyOLIIUAHHAZEXEX-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK429286A
-
Alternative nameGSK429286A
-